Designing Better Pediatric Medicines for Real-World Patient Needs

Cambridge, United States | 13 August 2026
Overview

Join us for a full-day event dedicated to advancing pediatric medicine, featuring expert-led sessions and networking opportunities. 

Hosted by the Quotient Sciences team, this event brings together leading professionals to discuss key topics in pediatric drug development, including taste and palatability assessments, regulatory considerations, food compatibility, formulation development, and patient acceptability.

The agenda includes presentations from renowned speakers, interactive Q&A sessions, and ample time for networking over lunch and a drinks reception. Whether you’re looking to deepen your expertise, connect with peers, or explore the latest innovations in pediatric science, this event promises valuable insights and engaging discussions.

  • Trends in pediatric drug development
  • Regulatory perspectives in PIP/PSP, pediatric QTPP, and excipient risk assessment
  • Formulation development pathways for pediatric products
  • Taste and palatability assessment approaches for pediatric dosage forms 
  • Patient centric design and acceptability in hospital settings
  • Food compatibility studies with pediatric dosage forms
  • Scale-up process development of pediatric dosage forms
TimeDescription
09:00 AM - 5:00 PMDuration
09:00 AM – 09:15 AMWelcome & Introduction - Nazim Kanji
09:15 AM – 10:00 AM

Daniel Schaufelberger (Schaufelberger Consulting) 

Topic: Trends, Targets, and Expectations for Pediatric New Product Development Q&A

10:00 AM – 10:45 AM

Mohan Ganapathy 

Topic: Pediatric Regs and Guidelines / Pediatric plans / QTPP / PERA

10:45 AM – 11:15 AMCoffee Break 
11:15 AM – 12:00 AM

Helen Baker (Quotient) 

Topic: Pediatric Formulation Development and Clinical Assessment (note: to incl flavor masking and taste assessments) Q&A 

12:00 AM – 12:45 PM

Rachel Meyers (Rutgers University) 

Topic: Patient Considerations for Pediatric Dosage Form Design / Pediatric Acceptability   Q&A

12:45 PM – 01:30 PMLunch & Networking
01:30 PM – 02:15 PM

Brad Rowe (Quotient) 

Topic: Food Compatibility Studies Q&A 

02:15 PM – 03:00 PMBob Cornog (Quotient)  Topic: LSCOM (title tbc)
03:00 PM – 05:00 PMDrinks reception | Closing Remarks Open floor for questions

 

Register
Location
MassBio
700 Technology Square, 5th Floor, MA 02139
Cambridge, United States

Meet our experts:

We look forward to meeting you at the seminar.

Nazim Kanji

Executive Director, Pediatric Services

Nazim Kanji has over 25 years of experience in the pharmaceutical and consumer healthcare industries, where he has worked in produ...

About Nazim
Dr. Helen Baker

Director, Formulation Design, Analytical Development

Dr. Helen Baker has over 15 years of formulation and product development experience within the pharmaceutical, biotech, and agrono...

About Helen
Brad Rowe

Senior Director, Integrated Development

Brad Rowe joined the organization in 2005 and is based from our Philadelphia, PA sites in Garnet Valley and Boothwyn. He joined QS...

About Brad
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...

About Robert
Daniel Schaufelberger, PhD

Pharmaceutical Executive

Daniel Schaufelberger, PhD is a pharmaceutical executive with over 30 years of experience in pharmaceutical development and drug d...

About Daniel
Rachel Meyers

Clinical Professor

Rachel Meyers is a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers University, and the Pediatric Clinical Pha...

About Rachel
Ganapathy Mohan, Ph.D

President, Mohan Pharma CMC Consulting LLC

Mohan retired from Merck in 2023 and has worked in the pharmaceutical industry for about 40 years.At Merck Mohan’s last position w...

About Mohan

More insight from our experts:

Read More
Translational Pharmaceutics, Solubility Enhancement, Modified Release, CRDMO Bridging In Vitro and In Vivo: Solubility Strategies for Modified Release Success
Learn more
Translational Pharmaceutics, Early Development, Clinical Pharmacology How Translational Pharmaceutics® Enhances Early Development Speed, Safety, and Confidence
Learn more